Abstract
Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.
Original language | English |
---|---|
Pages (from-to) | 203-211 |
Number of pages | 9 |
Journal | Urologic Clinics of North America |
Volume | 44 |
Issue number | 2 |
DOIs | |
State | Published - May 2017 |
Keywords
- Accuracy
- Biopsy
- Diagnosis
- Renal cell carcinoma
- Renal mass